Ingredion Incorporated (INGR) Stock Price & Analysis
Ingredion Incorporated (INGR) closed at USD 97.18 on Thursday, October 22, 2026, up 1.57% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 97.18; the Oct 22, 2026 session ranged USD 95.62–97.67 on volume of 1,110,236 shares. Market capitalization is —, with a 52-week range of USD 93.72–123.49 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:48 UTC.
Also available as compact Markdown for AI agents: nexqual.com/INGR.md
Key facts (INGR)
- Last four reported quarters (through Jun 30, 2026): revenue $7.21B, net income $592M (8.2% margin), free cash flow $355M (SEC filings).
- 1 of 80 tracked superinvestors hold INGR (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Hold (mean 2.57 on a 1–5 scale) (7 analysts), mean target USD 119.5 (range 104–150).
- Total return with dividends: 1Y -15.8% vs S&P 500 +14.9%; 5Y +15.5% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 2.61, revenue estimate $1.80B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (INGR)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $6.89B | $7.95B | $8.16B | $7.43B | $7.22B | $7.21B |
| Gross profit | $1.33B | $1.49B | $1.75B | $1.79B | $1.83B | — |
| Operating income | $310M | $762M | $957M | $883M | $1.02B | $860M |
| Net income | $117M | $492M | $643M | $647M | $729M | $592M |
| EPS (diluted) | $1.73 | $7.34 | $9.60 | $9.71 | $11.18 | — |
| Free cash flow | $92.0M | -$148M | $743M | $1.14B | $511M | $355M |
| Gross margin | 19.3% | 18.8% | 21.4% | 24.1% | 25.3% | — |
| Operating margin | 4.5% | 9.6% | 11.7% | 11.9% | 14.1% | 11.9% |
| Net margin | 1.7% | 6.2% | 7.9% | 8.7% | 10.1% | 8.2% |
| Revenue growth | +15.1% | +15.3% | +2.7% | -8.9% | -2.8% | — |
| Cash + short-term investments | $328M | $236M | $401M | $997M | $1.03B | — |
| Total debt | $2.05B | $2.48B | $2.19B | $1.83B | $1.79B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (INGR)
P/E at fiscal year-ends: Dec 2025 9.9x, Dec 2024 14.2x, Dec 2023 11.3x.
Superinvestors (SEC 13F-HR, Q2 2026) (INGR)
1 of 80 tracked investors hold INGR. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Yacktman Asset Management | 1.72% | $139M | Added +2.2% |
Analysts (INGR)
Consensus Hold (mean 2.57 on a 1–5 scale), 7 analysts; mean target USD 119.5 (low 104, high 150).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-14 | Barclays | Target lowered | Equal-Weight | $118 → $115 |
| 2026-10-05 | UBS | Target lowered | Neutral | $108 → $104 |
| 2026-08-05 | UBS | Target raised | Neutral | $104 → $108 |
| 2026-08-05 | Barclays | Target lowered | Equal-Weight | $120 → $118 |
Total return (dividends reinvested) (INGR)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -15.8% | +15.5% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -15.9% | +2.9% |
| Volatility (annualized) | 18.3% | 19.4% |
| Max drawdown | -20.8% (Feb 2026→Jun 2026) | -33.6% (Nov 2024→Oct 2026) |
INGR revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| T&HS | $662.0M | 35.8% | +8.9% |
| F&II–LATAM | $622.0M | 33.6% | +2.0% |
| F&II–U.S./Canada | $536.0M | 29.0% | -2.5% |
| Total revenue | $1.85B | 100% | — |
INGR revenue by region (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| U.S. Plans | $2.81B | 39.0% | -1.9% |
| Mexico | $1.39B | 19.3% | -7.4% |
| Other Countries | $982.0M | 13.6% | -0.4% |
| Brazil | $572.0M | 7.9% | -2.1% |
| Canada | $495.0M | 6.9% | -6.1% |
| Germany | $384.0M | 5.3% | -0.3% |
| Colombia | $324.0M | 4.5% | +4.5% |
| Thailand | $255.0M | 3.5% | -3.8% |
| Total revenue | $7.22B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
INGR suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | B3 | “Our pricing is determined through reference to the Chicago Board of Trade, a U.S. futures exchange, for corn we purchase from suppliers in the U.S., and through reference to B3 S.A., a Brazilian stock exchange and over-the-counter market, for corn we purchase from suppliers in Brazil.” |
Quoted from the company's 10-K filed Feb 17, 2026.
INGR analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $2.61 | $2.89 | -9.6% | $1.80B | 6 |
| Next quarter (ends Dec 2026) | $2.70 | $2.82 | -4.4% | $1.75B | 6 |
| Current fiscal year (ends Dec 2026) | $10.50 | $10.82 | -3.0% | $7.20B | 7 |
| Next fiscal year (ends Dec 2027) | $11.25 | $11.56 | -2.7% | $7.34B | 7 |
INGR options: expected move
Options price a move of about ±7.0% (±$6.78) by Nov 20, 2026, which includes earnings on Nov 5, 2026. Over the last 8 reports the stock moved ±4.4% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 30.3% | ±7.0% |
| Dec 18, 2026 | 56 | 26.8% | ±8.5% |
| Jan 15, 2027 | 84 | 25.2% | ±10.0% |
| Apr 16, 2027 | 175 | 25.4% | ±14.0% |
30-day implied volatility 27.6% vs 16.5% realized over the last 30 trading days. Put/call ratio (volume) 0.32. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:48 UTC)
| Price | USD 97.18 |
|---|---|
| Change | ▲ 1.57% (up) |
| Previous Close | USD 97.18 |
| Open | USD 97.18 |
| Day Range | USD 95.62 – 97.67 |
| 52-Week Range | USD 93.72 – 123.49 |
| Volume | 1,110,236 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (INGR)
Nexqual's technical model rates INGR "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:48 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.38 (neutral) |
| vs SMA50 | Below (USD 99.74) |
| MACD | -0.6 (negative) |
Analyst Ratings (INGR)
Wall Street analysts rate INGR "Hold" based on 7 analysts, with a mean price target of USD 119.5 (range USD 104–150), per Nexqual as of October 23, 2026 at 09:48 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 119.5 |
| High Target | USD 150 |
| Low Target | USD 104 |
| Buy / Hold / Sell | 2 / 5 / 0 |
Earnings (INGR)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 2.61 |
| Revenue Estimate | $1.80B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 2.82 vs est 2.72 ▲ beat |
| 2026-03-31 | USD 2.34 vs est 2.47 ▼ miss |
| 2025-12-31 | USD 2.53 vs est 2.61 ▼ miss |
| 2025-09-30 | USD 2.75 vs est 2.89 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:48 UTC.
Financials & Fundamentals (INGR)
| Total Revenue | $7.22B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +0.90% |
| Gross Margin | +23.73% |
| Operating Margin | +12.60% |
| Profit Margin | +8.20% |
| ROE | +13.69% |
| Debt / Equity | 0.39 |
| Current Ratio | 2.8 |
| Total Cash | $952.00M |
| Total Debt | $1.78B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $355.00M (4.9% of revenue) |
Source: Nexqual, October 23, 2026 at 09:48 UTC.
Financial Health Score (INGR)
Nexqual rates Ingredion Incorporated's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:48 UTC.
| Growth | Weak — Revenue -3% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 24%, operating 13% (last 12 months) |
| Balance Sheet | Strong — $948M cash and investments vs $1.78B debt (Jun 2026, SEC) |
| Cash Flow | Mixed — FCF $355M (last 4 quarters to Jun 2026, SEC), slim 4.9% margin |
| Efficiency | Mixed — ROE 14%, ROA 7.3% |
Ownership (INGR)
| Insider Ownership | +0.91% |
|---|---|
| Institutional Ownership | +101.31% |
| Shares Outstanding | 63.06M |
| Float | 62.58M |
| Short % of Float | +8.55% |
Source: Nexqual, October 23, 2026 at 09:48 UTC.
From Ingredion Incorporated's Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- As of December 31, 2025, we owned more than 1,800 patents and patents pending, which relate to a variety of products and processes, as well as a number of established trademarks under which we market our products.
Partnerships
- We collaborate with customers to develop specific application solutions either in the customers' facilities, in our Idea Labs® and technical service centers, or at third-party contractors.
Legal & Regulatory Risks (Item 1A, quoted)
- Changes in our tax rates or exposure to additional income tax liabilities could impact our profitability.
- We are subject to income taxes in the U.S. and in foreign jurisdictions. Our effective tax rates could be adversely affected by changes in the mix of earnings by jurisdiction, changes in tax laws, tax rate changes in the valuation of deferred tax assets and liabilities and material adjustments from tax audits.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CPB | The Campbell's Company | USD 21.26 | ▲ 8.69% |
| PPC | Pilgrim's Pride Corporation | USD 28.09 | ▲ 1.23% |
| CAG | ConAgra Brands, Inc. | USD 15.07 | ▲ 7.34% |
| SFD | Smithfield Foods, Inc. | USD 18.81 | ▲ 2.79% |
| LW | Lamb Weston Holdings, Inc. | USD 55.18 | ▲ 3.9% |
| DAR | Darling Ingredients Inc. | USD 55.64 | ▼ 5.84% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:48 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt